SCHEMBL5537496

SCHEMBL5537496

O=C(O)C1=C(c2ccc(CCCOc3c(F)ccc(F)c3Cl)cc2)CC2CNCC1N2

nearest known ligand 0.67

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
REN P00797 20/20 0.67
CTSD P07339 1/20 0.67
CTSE P14091 1/20 0.67
CYP3A4 P08684 3/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5537522 1.00 REN (0.67) RENCTSDCTSECYP3A4
SCHEMBL5537504 1.00 REN (0.67) RENCTSDCTSECYP3A4
SCHEMBL5076986 0.91 REN (0.56) RENCTSDCTSECYP3A4
SCHEMBL5076994 0.91 REN (0.56) RENCTSDCTSECYP3A4
SCHEMBL6432041 0.91 REN (0.56) RENCTSDCTSECYP3A4
SCHEMBL5081106 0.91 REN (0.56) RENCTSDCTSECYP3A4
SCHEMBL6432046 0.91 REN (0.56) RENCTSDCTSECYP3A4
SCHEMBL5076989 0.91 REN (0.56) RENCTSDCTSECYP3A4
SCHEMBL5466055 0.89 REN (0.67) RENCTSDCTSECYP3A4
SCHEMBL5466052 0.89 REN (0.67) RENCTSDCTSECYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1824851-A2 NOVEL DIAZABICYCLONONENE DERIVATIVE Actelion Pharmaceuticals Ltd. (CH) 2007-08-29 EP disclosed
WO-2006061791-A2 NOVEL DIAZABICYCLONONENE DERIVATIVE ACTELION PHARMACEUTICALS LTD (CH) 2006-06-15 WO disclosed